US Patent Issued Protecting BARD1 Ovarian Test
Filed with ASX · · 2 pages · English
Story so far
Earlier from Inoviq
- Improved Performance of BARD1 Ovarian Test
- Contract Development Agreement Signed
- Voluntary Suspension
- Capital Raising
- Israeli Patent Issued in Bard1 Core Patent Family
Later from Inoviq
- Quarterly Activities Report and Appendix 4C
- Appendix 4E
- Bard1 Ovarian Test Results
- Development of world first BARD1 Breast Cancer Test
- Grant of Additional Chinese Patent Core BARD1 Patent Family
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq